Target intelligence / Profile preview

Dirofilaria immitis (Null)

Target
Null
Molecular classification
Other
01

Overview

Dirofilaria immitis is a parasitic roundworm (nematode) of the family Onchocercidae that causes heartworm disease in dogs and other mammals, including rarely humans. The adult worms inhabit the pulmonary arteries and sometimes the right side of the heart, leading to severe cardiovascular and pulmonary pathology if untreated. Transmission occurs through the bite of infected mosquitoes, which act as intermediate hosts. The primary hosts in nature are dogs and wild canids; cats, ferrets, and occasional other mammals can be infected. Dirofilaria immitis is not a molecular “target” such as a receptor, enzyme, or transporter, but rather an organism (parasite) subject to therapeutic intervention with antiparasitic drugs[2][7][6][4].

Other names
Dog heartwormheartworm
02

Mechanism of action

Macrocyclic lactones (e.g., ivermectin, moxidectin, selamectin) kill larval stages (microfilariae, L3, and L4). Adulticides (melarsomine) kill adult worms. Doxycycline targets Wolbachia endosymbionts, weakening the parasite[2].

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Drug resistanceadverse reactions to rapid worm death (pulmonary thromboembolism)allergic reactions to microfilariae or dead wormsoff-target toxicity (neurotoxicity for some drug classes in sensitive breeds)possible anaphylaxis secondary to rapid die-off
06

Interacting drugs

Ivermectin

5 more in the full profile.

07

Biomarkers

Presence of circulating microfilariae in bloodantigen detection for mature female wormsradiographic “coin lesion” in humans

Beyond the preview

Go deeper on Dirofilaria immitis (Null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dirofilaria immitis (Null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call